{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:10Z","timestamp":1794057730666,"version":"4.8.0"},"reference-count":20,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: To describe cases of retinal vascular events shortly after administration of mRNA or adenoviral-vectored COVID-19 vaccines. Design: Retrospective, multicenter case series. Methods: Six cases of retinal vascular events shortly after receiving COVID-19 vaccines. Results: A 38-year-old, otherwise healthy male patient presented with branch retinal arterial occlusion four days after receiving his second dose of SARS-CoV-2 vaccination with Comirnaty\u00ae (BioNTech\u00ae, Mainz, Germany; Pfizer\u00ae, New York City, NY, USA). An 81-year-old female patient developed visual symptoms twelve days after the second dose of SARS-CoV-2 vaccination with Comirnaty\u00ae and was diagnosed with a combined arterial and venous occlusion in her right eye. A 40-year-old male patient noticed blurry vision five days after his first dose of SARS-CoV-2 vaccination with Comirnaty\u00ae and was diagnosed with venous stasis retinopathy in his left eye. A 67-year-old male was diagnosed with non-arteritic anterior ischemic optic neuropathy in his right eye four days after receiving the first dose of Vaxzevria\u00ae (AstraZeneca\u00ae, Cambridge, UK). A 32-year-old man presented with a sudden onset of a scotoma two days after receiving the second dose of SARS-CoV-2 vaccination with Spikevax\u00ae (Moderna, Cambridge, UK) and was diagnosed with a circumscribed nerve fiber infarction. A 21-year-old female patient developed an acute bilateral acute macular neuroretinopathy three days after receiving the first dose of SARS-CoV2-vaccine Vaxzevria\u00ae (AstraZeneca\u00ae, Cambridge, UK). Conclusion: This case series describes six cases of retinal vascular events shortly after receiving mRNA or adenoviral-vectored COVID-19 vaccines. The short time span between received vaccination and occurrence of the observed retinal vascular events raises the question of a direct correlation. Our case series adds to further reports of possible side effects with potential serious post-immunization complications of COVID-19 vaccinations.<\/jats:p>","DOI":"10.3390\/vaccines9111349","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T21:32:07Z","timestamp":1637184727000},"page":"1349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines\u2014A Case Series"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-9617","authenticated-orcid":false,"given":"Christian","family":"Girbardt","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Hospital Leipzig Medical Center, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-4663","authenticated-orcid":false,"given":"Catharina","family":"Busch","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Leipzig Medical Center, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayss","family":"Al-Sheikh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-347X","authenticated-orcid":false,"given":"Jeanne Martine","family":"Gunzinger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Invernizzi","sequence":"additional","affiliation":[{"name":"Eye Clinic, Department of Biomedical and Clinical Sciences \u201cLuigi Sacco\u201d, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy"},{"name":"Save Sight Institute, Discipline of Ophthalmology, Sydney Medical School, The University of Sydney, Sydney, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1847-8726","authenticated-orcid":false,"given":"Alba","family":"Xhepa","sequence":"additional","affiliation":[{"name":"Eye Clinic, Department of Biomedical and Clinical Sciences \u201cLuigi Sacco\u201d, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Darius","family":"Unterlauft","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Leipzig Medical Center, 04103 Leipzig, Germany"},{"name":"Department of Ophthalmology, University Hospital Bern, Inselspital, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matus","family":"Rehak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Leipzig Medical Center, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"iqab010","DOI":"10.1093\/oxfimm\/iqab010","article-title":"Overview of approved and upcoming vaccines for SARS-CoV-2: A living review","volume":"2","author":"Alderson","year":"2021","journal-title":"Oxf. Open Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai","year":"2021","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2101111","DOI":"10.1183\/13993003.01111-2021","article-title":"Thrombotic complications of vaccination against SARS-CoV-2: What pharmacovigilance reports tell us - and what they don\u2019t","volume":"58","author":"Konstantinides","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/eye.2011.92","article-title":"The burden of disease of retinal vein occlusion: Review of the literature","volume":"25","author":"Laouri","year":"2011","journal-title":"Eye"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41433-019-0576-y","article-title":"Risk of acute stroke in patients with retinal artery occlusion: A systematic review and meta-analysis","volume":"34","author":"Fallico","year":"2020","journal-title":"Eye"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e041104","DOI":"10.1136\/bmjopen-2020-041104","article-title":"Nationwide incidence of central retinal artery occlusion in Japan: An exploratory descriptive study using the National Database of Health Insurance Claims (2011-2015)","volume":"10","author":"Kido","year":"2020","journal-title":"BMJ Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"724780","DOI":"10.1155\/2014\/724780","article-title":"Risk factors for central and branch retinal vein occlusion: A meta-analysis of published clinical data","volume":"2014","author":"Kolar","year":"2014","journal-title":"J. Ophthalmol."},{"key":"ref_11","first-page":"38","article-title":"Transthoracic echocardiography in young patients with acute retinal arterial obstruction. RECO Study Group. Retinal Emboli of Cardiac Origin Group","volume":"32","author":"Sharma","year":"1997","journal-title":"Can. J. Ophthalmol. J. Can. d\u2019ophtalmologie"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00115-018-0609-y","article-title":"Cryptogenic stroke and patent foramen ovale: S2e guidelines","volume":"89","author":"Diener","year":"2018","journal-title":"Der Nervenarzt"},{"key":"ref_13","first-page":"1","article-title":"Acute macular neuroretinopathy following COVID-19 vaccination","volume":"22","author":"Bohler","year":"2021","journal-title":"Eye"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.survophthal.2016.03.003","article-title":"Acute macular neuroretinopathy: A comprehensive review of the literature","volume":"61","author":"Bhavsar","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajoc.2018.02.008","article-title":"Acute macular neuroretinopathy associated with influenza vaccination with decreased flow at the deep capillary plexus on OCT angiography","volume":"10","author":"Liu","year":"2018","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2100956","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: Insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for Adverse Events After COVID-19 mRNA Vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"bcr2015211971","DOI":"10.1136\/bcr-2015-211971","article-title":"Retinal artery vasculitis secondary to administration of influenza vaccine","volume":"2015","author":"Williams","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0140-6736(96)91112-5","article-title":"Occlusion of central retinal vein after hepatitis B vaccination","volume":"347","author":"Devin","year":"1996","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ng, X.L., Betzler, B.K., Testi, I., Ho, S.L., Tien, M., and Ngo, W.K. (2021). Ocular Adverse Events After COVID-19 Vaccination. Ocul. Immunol. Inflamm., 1\u20139.","DOI":"10.1080\/09273948.2021.1976221"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/11\/1349\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:31:52Z","timestamp":1760167912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/11\/1349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["vaccines9111349"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9111349","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]}}}